HomeCompareTIGE vs MRK

TIGE vs MRK: Dividend Comparison 2026

TIGE yields 1000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TIGE wins by $4.7683925249533696e+36M in total portfolio value
10 years
TIGE
TIGE
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full TIGE calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TIGE vs MRK

📍 TIGE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTIGEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TIGE + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TIGE pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TIGE
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TIGE beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TIGE + MRK for your $10,000?

TIGE: 50%MRK: 50%
100% MRK50/50100% TIGE
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TIGE
No analyst data
Altman Z
-0.6
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TIGE buys
0
MRK buys
0
No recent congressional trades found for TIGE or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTIGEMRK
Forward yield1000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.7683925249533696e+36M$56.8K
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$4.7683311610149396e+36M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TIGE vs MRK ($10,000, DRIP)

YearTIGE PortfolioTIGE Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,206$366.19+$100.00MTIGE
2$934,786,450,701$934,679,439,252.34$12,650$502.35+$934786.44MTIGE
3$8,165,787,108,578,292$8,164,786,887,076,042.00$14,407$694.19+$8165787108.56MTIGE
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$16,585$967.82+$66665884190957.63MTIGE
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$19,342$1,363.89+$508662171058048128.00MTIGE
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$22,913$1,947.19+$3.62723524842849e+21MTIGE
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$27,662$2,823.89+$2.417368115915061e+25MTIGE
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$34,159$4,173.35+$1.5056740286145463e+29MTIGE
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$43,337$6,308.80+$8.764771002818475e+32MTIGE
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$56,776$9,798.13+$4.7683925249533696e+36MTIGE

TIGE vs MRK: Complete Analysis 2026

TIGEStock

Tigrent Inc., together with its subsidiaries, provides practical value-based training, conferences, publications, technology-based tools, and mentoring services. It offers instruction and mentoring on the topics of real estate, financial instruments investing, and entrepreneurship in the United States, the United Kingdom, and Canada. The company's training courses include Building Wealth, a curriculum focused on real estate and the fundamentals of negotiating real estate purchases with sellers, rehabilitating distressed properties, and leasing rental units to tenants; and Making Money from Property with Martin Roberts, a real estate curriculum focused on property auctions. Its training courses also comprise Teach Me To Trade, a curriculum focused on financial instrument trading strategies using software and specific teaching techniques; Women in Wealth that teaches women how to take control of their financial circumstances; and Business Success Systems, a business basics curriculum focused on the small business ideas and opportunities that are available to individuals. The company, through its licensing agreement with Rich Global, markets various courses and training programs under the Rich Dad brand, including Rich Dad Learn to be Rich that focuses on real estate training; and Rich Dad Stock Success, which concentrates on financial instruments training. Tigrent Inc. enables customers to access training content through various delivery channels, including live instruction in classroom settings, onsite mentoring, telephonic coaching, conferences, teleconferences, and electronic media, as well as electronic access to live online or pre-recorded on-demand programs. The company was formerly known as Whitney Information Network, Inc. and changed its name to Tigrent Inc. in September 2009. Tigrent Inc. was founded in 1992 and is based in Cape Coral, Florida.

Full TIGE Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TIGE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TIGE vs SCHDTIGE vs JEPITIGE vs OTIGE vs KOTIGE vs MAINTIGE vs JNJTIGE vs ABBVTIGE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.